By abbie uychiat
SAN FRANCISCO - APRIL 24: A
worker at the Alternative Herbal Health Services cannabis dispensary
rolls a marijuana cigarette April 24, 2006 in San Francisco, California.
The Food and Drug Administration issued a statement last week rejecting
the use of medical marijuana declaring that there is no scientific
evidence supporting use of the drug for medical treatment. (Photo :
Justin Sullivan / Staff)
Marijuana
is known to have numerous medical benefits, and as of the most recent
news, FDA admitted that marijuana can in fact cure cancer. Cancer and
chronic pain may be the most common ailments that marijuana can cure,
but recent studies revealed that Cannabidol, a compound found in pot,
can help manage Parkinson's disease.
As per Leaf Science,
"New research suggests a compound in marijuana can help manage symptoms
of Parkinson's disease." It is a chronic, degenerative disorder that
usually targets elderly people. One of which is Alzheimer's, which is
known to be a disease where in an elderly would have a progressive loss
of neurons in the brain.
a recent studies emerged that
cannabidiol, which is a non-psychoactive compound that is naturally
produced by the marijuana plant. It has an anti-inflammatory and
anti-oxidant property that has the potential to treat Alzheimer's.
As per Green Med info
website Parkinson's disease have no effective treatment at present.
The primary treatment however involves the usage of doapamine increasing
drugs that can possibly increase a 6-hydroxy-doapamine, which can
however accelerate the progression of the disease.
This being said,
rec]searchers have been looking for ways that would have less harmful
effects, which is why they opted to try incorporating the marijuana
compound cannabidiol.
"In the first one, Lastres-Becker
et al. (2005) showed that the administration of CBD counteracted
neurodegeneration caused by the injection of 6-hydroxy-dopamine in the
medial prosencephalic bundle, an effect that could be related to the
modulation of glial cells and to antioxidant effects (Lastres- Becker et
al., 2005).
In the next year, Garcia-Arencibia et al. (2007) tested
many cannabinoid compounds following the lesion of dopaminergic neurons
in the substantia nigra with 6-hydroxy-dopamine and found that the acute
administration of CBD seemed to have a neuroprotective action;
nonetheless, the administration of CBD one week after the lesion had no
significant effects (Garcia-Arencibia et al., 2007).
This study also
pointed to a possible antioxidant effect with the upregulation of mRNA
of the enzyme Cu-Zn-superoxide dismutase following the administration of
CBD."
As of the study's conclusion, the
website reported that it did have positive effects on three of the
human clinical trials that was conducted using cannabidiol's
neuroprotective effects.
No comments:
Post a Comment